Methotrexate (2.5mg tablets)
Brand:
NICE TA:
Indication: Rheumatic diseases
Disease category: Musculoskeletal and joint diseases
Commissioning responsibility: CCG
PbR excluded: No
Background
LMMG is adopting the local decisions made prior to April 2013
Recommendation
LMMG recommendation: Amber2
Click here to find the definitions for the colour classifications
Reason for decision: Requires significant monitoring
Supporting documents:
Methotrexate Shared Care Guideline Version 2.2 (240.6 KiB)
DMARDs Shared Care Agreement V1.1 (124.0 KiB)
**Please note - For Fylde & Wyre CCG DMARD Shared Care Guidelines please use the versions available on the CCG website
**Please note - For Blackpool CCG DMARD Shared Care Guidelines please use the versions available on the CCG website
Decisions of Lancashire local decision making groups:
NHS Blackburn With Darwen CCG and NHS East Lancashire CCG | NHS Blackpool CCG | NHS Chorley and South Ribble CCG and NHS Greater Preston CCG | NHS Fylde and Wyre CCG | NHS Morecambe Bay CCG | NHS West Lancashire CCG |
---|---|---|---|---|---|
Amber2 |
Amber2 |
Amber2 |
Amber2 |
Amber2 |
Amber2 |